Clinical Trial

Comparison of Early Pleural Irrigation Strategy With Saline to the Standard of Care for the Management of Complicated Pleural Infections.

Study acronym: EPISSOC
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Intrapleural enzyme therapy (IET) is regarded by recent guidelines as a "rescue" therapy for managing complicated pleural infections; however, it is associated with significant side effects, including pleural bleeding, pain, and fever. Pleural irrigation with saline may serve as an alternative, yet evidence supporting its effectiveness is limited to a single small- scale, single-center randomized trial. The objective of the study is to compare the risk of treatment failure at 30 days (defined as a composite outcome that includes death, the need for thoracic surgery, or additional intrapleural enzyme therapy) between an early pleural irrigation strategy and standard care for complicated pleural infections.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-18.
Trial Details
NCT Number NCT07666464
Lead Sponsor Centre Hospitalier Universitaire, Amiens
Collaborators: University Hospital, Toulouse, Central Hospital Saint Quentin, CRC CHI Creteil France, University Hospital, Tours, Centre Hospitalier Universitaire de Nīmes, University Hospital, Brest, CH Morlaix, University Hospital, Caen, University Hospital, Rouen, University Hospital, Angers, Hospices Civils de Lyon, CH Pontoise, CH Avignon, Centre Hospitalier VALENCIENNES, CH Le Havre, Tenon Hospital, Paris, University Hospital, Bordeaux, Centre Hospitalier Argenteuil, University Hospital, Strasbourg, France, Nantes University Hospital, CH Haguenau, CHU de Reims, Centre Hospitalier Alpes Leman, Central Hospital, Nancy, France
Conditions Therapy, Pleural Infections
Enrollment 244 participants
Start Date 2026-05-13
Primary Completion 2029-05 (estimated)
Study Completion 2029-08 (estimated)
Updated on ClinicalTrials.gov 2026-07-01